Collagenase Injection as Nonsurgical Treatment of Dupuytren's Disease: 8-Year Follow-Up
To access this article, please choose from the options below
C.M.C. received compensation for participation in the phase III clinical trial of injectable collagenase.
Institutional funding of phase III clinical trials provided by Auxilium. No funding was received by the authors or the institution for the completion of this study. The authors have no financial interest in injectable collagenase or Auxilium. No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.
PII: S0363-5023(10)00004-3
doi:10.1016/j.jhsa.2010.01.003
© 2010 Published by Elsevier Inc.

